Literature DB >> 32967412

MUC1 and MUC5AC implication in Tunisian colorectal cancer patients

Meriam Hazgui1,2, Marwa Weslati1,2, Rahma Boughriba1,2, Donia Ounissi1,2, Dhouha Bacha3, Saadia Bouraoui1,3.   

Abstract

Background/aim: Mucins, such as MUC1 and MUC5AC, are known for their protective and moisturizing role in intestinal epithelium. Their expression is tightly controlled given their essential role in normal tissue homeostasis, whereas their deregulation leads to chronic inflammation, and even cancer. This study aimed to assess the expression profiles of MUC1 and MUC5AC and their implications in colorectal carcinogenesis. Materials and methods: A retrospective study of 202 patients who underwent colorectal cancer (CRC) surgery was conducted. The expression of MUC1 and MUC5AC was investigated by immunohistochemistry and reverse-transcription polymerase chain reaction (RT-PCR). Statistical analysis of mucin expression pattern, as well as the clinicopathological criteria of the patients, was performed using the chi-square test, survival curves were plotted using the Kaplan—Meier product-limit method, and differences between the survival curves were tested using the log-rank test.
Results: The expression of both mucins was abnormally high in the tumor tissues for both mRNA and protein. MUC1 expression was correlated with advanced cancer stages and lymph node metastases for both the mRNA (P < 0.016 and P < 0.002, respectively) and protein level (P < 0.006 and P < 0.001, respectively). However, MUC5AC expression did not pinpoint any significant association between the clinicopathological criteria, but patients who expressed MUC5AC showed an increase in overall survival (P < 0.009).
Conclusion: The expression of MUC1 might be a poor prognostic biomarker in CRC and could play a role in tumor transformation and metastasis. However, MUC5AC expression might be a good prognostic in the Tunisian cohort. This work is licensed under a Creative Commons Attribution 4.0 International License.

Entities:  

Keywords:  Colorectal cancer; MUC1; MUC5AC; immunohistochemistry; RT-PCR

Year:  2021        PMID: 32967412      PMCID: PMC7991860          DOI: 10.3906/sag-2003-29

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  32 in total

1.  Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.

Authors:  Michael D Walsh; Mark Clendenning; Elizabeth Williamson; Sally-Ann Pearson; Rhiannon J Walters; Belinda Nagler; David Packenas; Aung K Win; John L Hopper; Mark A Jenkins; Andrew M Haydon; Christophe Rosty; Dallas R English; Graham G Giles; Michael A McGuckin; Joanne P Young; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-06-28       Impact factor: 7.842

2.  A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.

Authors:  Sukhwinder Kaur; Lynette M Smith; Asish Patel; Melanie Menning; Duncan C Watley; Saad S Malik; Shiv Ram Krishn; Kavita Mallya; Abhijit Aithal; Aaron R Sasson; Sonny L Johansson; Maneesh Jain; Shailender Singh; Sushovan Guha; Chandrakanth Are; Massimo Raimondo; Michael A Hollingsworth; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

3.  Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

Authors:  Xiao-Dong Bu; Nan Li; Xiao-Qiang Tian; Li Li; Jin-Song Wang; Xiao-Jin Yu; Pei-Lin Huang
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.

Authors:  Yanbin Jia; Christina Persson; Lifang Hou; Zongli Zheng; Meredith Yeager; Jolanta Lissowska; Stephen J Chanock; Wong-Ho Chow; Weimin Ye
Journal:  Cancer Causes Control       Date:  2010-02       Impact factor: 2.506

Review 5.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

6.  Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer.

Authors:  Milad Javanbakht; Jamal Akhavanmoghadam; Amir Jouya Talaei; Maryam Aghyani; Mohamad Mozafari; Leila Khedmat; Mahdi Mohebbi
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09-18       Impact factor: 2.557

7.  Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease.

Authors:  Anna E Furr; Sarangarajan Ranganathan; Olivera J Finn
Journal:  Pediatr Dev Pathol       Date:  2010 Jan-Feb

Review 8.  Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-Analysis.

Authors:  Feng Xu; Fuquan Liu; Hongwei Zhao; Guangyu An; Guosheng Feng
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

9.  Differential expression of mucin 1 and mucin 2 in colorectal cancer.

Authors:  Aldona Kasprzak; Elżbieta Siodła; Małgorzata Andrzejewska; Jacek Szmeja; Agnieszka Seraszek-Jaros; Szczepan Cofta; Witold Szaflarski
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

10.  Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.

Authors:  Ramesh Pothuraju; Satyanarayana Rachagani; Shiv Ram Krishn; Sanjib Chaudhary; Rama Krishna Nimmakayala; Jawed A Siddiqui; Koelina Ganguly; Imayavaramban Lakshmanan; Jesse L Cox; Kavita Mallya; Sukhwinder Kaur; Surinder K Batra
Journal:  Mol Cancer       Date:  2020-02-25       Impact factor: 27.401

View more
  2 in total

1.  Understanding the mechanisms of gallbladder lesions: A systematic review.

Authors:  Andrei Bojan; Liliana Georgeta Foia; Maria Cristina Vladeanu; Iris Bararu Bojan; Carmen Plesoianu; Alexandru Plesoianu; Catalin Pricop
Journal:  Exp Ther Med       Date:  2022-07-29       Impact factor: 2.751

Review 2.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.